Targeting Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer by Inducing Epidermal Growth Factor Receptor Degradation via Methionine 790 Oxidation

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been developed to treat non-small cell lung cancer (NSCLC) patients with EGFR mutation, but TKI resistance is common. Almost half of the acquired resistance patients are due to additional T790M mutation on EGFR (EGFR(T790...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antioxidants & redox signaling 2016-02, Vol.24 (5), p.263-279
Hauptverfasser: Leung, Elaine Lai-Han, Fan, Xing-Xing, Wong, Maria Pik, Jiang, Zhi-Hong, Liu, Zhong-Qiu, Yao, Xiao-Jun, Lu, Lin-Lin, Zhou, Yan-Ling, Yau, Li-Fong, Tin, Vicky Pui-Chi, Liu, Liang
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!